SARS-CoV-2 targeting recombinant methioninase (CoronaCure)

N/A

Report date: 2025/01/26 16:18:21

Base Information

Drug NameSARS-CoV-2 targeting recombinant methioninase (CoronaCure)
Drug Alias Namerecombinant methioninase (Anticancer)recombinant methioninase (Anticancer)SARS-CoV-2 targeting recombinant methioninase (AntiCancer)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnticancer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoronaCure LLC
Inactive CompaniesAnticancer Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A